31例胸腺瘤外科治疗分析

目的总结胸腺瘤外科治疗的临床特点。方法对2012-01—2014-06经31例行外科手术治疗的胸腺瘤患者的临床资料进行回顾性分析。结果胸腺瘤合并重症肌无力23例(74.2%)。全组完全切除率为87.1%。临床Ⅰ、Ⅱ期完全切除率100%,Ⅲ期完全切除率66.7%。全组无手术死亡。80.0%的A型和75.0%AB型分布在Ⅰ期,而100%的B3型分布在Ⅲ期。AB型胸腺瘤中合并重症肌无力占50%,其余各型中合并重症肌无力的比例均超过50%。结论胸腺瘤组织学分型与临床分期有密切关系,二者结合对判断预后更准确。AB型胸腺瘤患者中合并重症肌无力的比例最低,其余各型合并重症肌无力的比例则较大,诊治胸腺瘤患者时需警惕是否合并重症肌无力。

Clinical characteristics of thymoma with surgical treatment 31 cases

Objective To explore the clinical characteristics of the thymoma with surgical treament. Methods The clinical treatment materials of 31 cases with thymoma underwent surgical treatment from Jan 2012 to Jun 2014 were retrospectively analyzed. Results Among these 31cases,there are 23cases combined MG(74. 2% ). The complete resection(CR)ratio was 87. 1% ,and 100% of patients in stage Ⅰ andⅡ obtain CR. Only 66. 7% of patients in stage Ⅰ and Ⅱ reach CR. There are no patient died after operation. There are 80. 0% of A and 75. 0% of AB type of thymoma distributed in the stage Ⅰ;and 100% of B3 in the stage Ⅲ. There are 50% of patients combined MG in AB type of thymoma,and more proportion in the other type of thymoma. Conclusion The histological classification were closed relationed with the Masaoka stages. A combination of the histological classification and the Masaoka stages can increase the accuracy of prognosis. The proportion of thymoma combined MG is high,and we should pay more attention to MG when thymoma is diagnosed.